Publication | Open Access

Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma

InflammationAsthmaAllergyInflammatory Lung DiseaseLung InflammationAllergy MedicineMedicineMurine ModelImmunologyAllergenEosinophilic DisorderSerine Protease InhibitorsPharmacology